Has the UK been best place in the world to invest in life sciences?
Swiss company looks move on from Tamiflu scandal
Failure to strike a Brexit deal allowing alignment with the European Medicines Agency would be ‘catastrophic’ for the UK life sciences sector.
The UK can be a leader in cell and gene therapy, but Brexit is a once-in-a-generation challenge
How contributions from the updated PPRS have affected the DH budget for the NHS.